Q1 2018 Holdings
Filed 2018-05-10 | 110 holdings | $242.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $100.8M | 600,000 | 41.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $71.5M | 600,000 | 29.5% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $40.9M | 500,000 | 16.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $12.1M | 150,000 | 5.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $4.6M | 300,000 | 1.9% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $4.5M | 475,000 | 1.9% |
| Blue Buffalo PET Prods Inc | COM | 09531U102 | $3.5M | 87,460,875 | 1.4% |
| Weight Watchers Intl Inc New | COM | 948626106 | $1.9M | 29,443,300 | 0.8% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $499.4K | 58,274,650 | 0.2% |
| Spdr S&P 500 ETF TR(SPY)Call | TR UNIT | 78462F103 | $131.6K | 500,000 | 0.1% |
| Bank Amer Corp(BAC)Call | COM | 060505104 | $130.5K | 4,350,000 | 0.1% |
| General Mtrs Co(GM)Call | COM | 37045V100 | $127.2K | 3,500,000 | 0.1% |
| International Business Machs(IBM)Call | COM | 459200101 | $92.1K | 600,000 | 0.0% |
| Goldman Sachs Group Inc(GS)Call | COM | 38141G104 | $88.2K | 350,000 | 0.0% |
| Exxon Mobil Corp(XOM)Call | COM | 30231G102 | $74.6K | 1,000,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $74.4K | 700,000 | 0.0% |
| Wells Fargo Co New(WFC)Call | COM | 949746101 | $68.1K | 1,300,000 | 0.0% |
| Celgene Corp(CELG)Call | COM | 151020104 | $58.0K | 650,000 | 0.0% |
| Chevron Corp New(CVX)Call | COM | 166764100 | $57.0K | 500,000 | 0.0% |
| Bristol Myers Squibb Co(BMY)Call | COM | 110122108 | $56.9K | 900,000 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $48.8K | 1,250,000 | 0.0% |
| Incyte Corp(INCY)Call | COM | 45337C102 | $45.8K | 550,000 | 0.0% |
| Spdr Series Trust(XBI)Call | S&P BIOTECH | 78464A870 | $43.9K | 500,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $41.3K | 450,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $37.6K | 2,500,000 | 0.0% |
| Tesaro Inc | COM | 881569107 | $34.3K | 600,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $33.2K | 850,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $32.6K | 2,000,000 | 0.0% |
| Caterpillar Inc del(CAT)Call | COM | 149123101 | $29.5K | 200,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $25.6K | 150,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $25.0K | 300,000 | 0.0% |
| Medicines CoCall | COM | 584688105 | $23.1K | 700,000 | 0.0% |
| Nektar Therapeutics(NKTREUR)Call | COM | 640268108 | $21.3K | 200,000 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $19.8K | 190,000 | 0.0% |
| Avexis Inc | COM | 05366U100 | $19.8K | 160,000 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $17.8K | 547,841 | 0.0% |
| Freeport-Mcmoran Inc(FCX)Call | CL B | 35671D857 | $17.6K | 1,000,000 | 0.0% |
| Regeneron Pharmaceuticals(REGN)Call | COM | 75886F107 | $17.2K | 50,000 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN)Call | COM | 015351109 | $16.7K | 150,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX)Call | COM | 92532F100 | $16.3K | 100,000 | 0.0% |
| Biomarin Pharmaceutical Inc(BMRN)Call | COM | 09061G101 | $16.2K | 200,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $16.1K | 100,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD)Call | COM | 03152W109 | $13.5K | 900,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR)Call | COM | 189464100 | $13.2K | 250,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $13.0K | 2,750,000 | 0.0% |
| Iqiyi Inc(IQ) | SPONSORED ADS | 46267X108 | $11.7K | 750,000 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $11.6K | 250,000 | 0.0% |
| Accelerate Diagnostics Inc | COM | 00430H102 | $11.4K | 500,000 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $10.8K | 300,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $9.7K | 200,000 | 0.0% |